Hormone therapy impairs endothelial function in postmenopausal women with type 2 diabetes mellitus treated with rosiglitazone.

Honisett, Suzy Y

Hormone therapy impairs endothelial function in postmenopausal women with type 2 diabetes mellitus treated with rosiglitazone. [electronic resource] - The Journal of clinical endocrinology and metabolism Sep 2004 - 4615-9 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial

0021-972X

10.1210/jc.2003-031414 doi


Aged
Blood Pressure
Coronary Disease--etiology
Cross-Over Studies
Diabetes Mellitus, Type 2--drug therapy
Double-Blind Method
Endothelium, Vascular--drug effects
Estradiol--administration & dosage
Female
Hormone Replacement Therapy--adverse effects
Humans
Lipids--blood
Middle Aged
Postmenopause
Progesterone--administration & dosage
Receptors, Cytoplasmic and Nuclear--metabolism
Rosiglitazone
Thiazolidinediones--therapeutic use
Transcription Factors--metabolism